Table 1. Participant characteristics.
Variable | Resistance (n = 17) | Balance (n = 15) | p-value a |
---|---|---|---|
Age (yr) | 75.7 ± 5.5 | 75.7 ± 7.2 | 0.882 |
No. of female subjects | 5 (29.4%) | 6 (40%) | 0.529 b |
Duration of Disease (yr) | 10.1 ± 6.0 | 9.3 ± 7.9 | 0.455 |
BMI (kg/m2) | 27.9 ± 5.5 | 25.5 ± 4.4 | 0.142 |
H&Y | 2.8 ± 0.26 | 2.7 ± 0.4 | 0.216 |
H&Y (Range) | 2.5–3.0 | 2.5–3.0 | n/a |
UPDRS total (ON) | 40.2 ± 12.5 | 37.7 ± 13.1 | 0.455 |
UPDRS part II (ON) | 13.4 ± 5.1 | 11.1 ± 6.0 | 0.105 |
UPDRS part III (ON) | 23.6 ± 9.5 | 22.3 ± 6.1 | 0.941 |
FAB scale | 22.2 ± 4.8 | 24.5 ± 4.6 | 0.123 |
MMSE | 27.3 ± 3.6 | 27.7 ± 3.0 | 0.891 |
MMSE (Range) | 17–30 | 20–30 | n/a |
PASE score | 104.6 ± 87.3 | 77.2 ± 63.1 | 0.576 |
LEDD (mg/day) | 817.4 ± 468.0 | 674.7 ± 294.9 | 0.318 |
If not indicated differently, values are either mean ± SD or number and percentage. BMI, Body-Mass-Index; FAB, Fullerton Advanced Balance; H&Y, Hoehn & Yahr; LEDD, levodopa equivalent daily dose; MMSE, Mini-Mental State Examination; PASE, Physical Activity Scale for the Elderly; UPDRS, Unified Parkinson’s Disease Rating Scale
a unless otherwise indicated P-value of independent samples Mann-Whitney-U-Test
b P-value of Chi-Square Test.